Bioactive peptides from fermented foods and health promotion

Advances in Fermented Foods and Beverages: Improving Quality, Technologies and Health Benefits

Volumn , Issue , 2014, Pages 39-40

  Pihlanto, A ^a   Korhonen, H ^a  

^a FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

Bioactive peptides; Cardiovascular health; Fermentation; Health effects; Milk; Soy

Indexed keywords

BLOOD PRESSURE; FERMENTATION; FERMENTED MILK; HEALTH;

ANTI-HYPERTENSIVE ACTIVITIES; BIOACTIVE PEPTIDES; BIOACTIVE PROPERTIES; FERMENTED DAIRY PRODUCTS; HEALTH EFFECTS; MILK; SPONTANEOUSLY HYPERTENSIVE RATS; SYSTOLIC BLOOD PRESSURE;

PEPTIDES;

EID: 84941195081     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-78242-015-6.00003-7     Document Type: Chapter

References (169)

1. Addeo F., Chianese L., Salzano A., Sacchi R., Cappuccio U., Ferranti P., et al. Characterization of the 12% trichloroacetic acid-insoluble oligopeptides of Parmigiano-Reggiano cheese. Journal of Dairy Research 1992, 59:401-411.
2. Aihara K., Kajimoto O., Hirata H., Takahashi R., Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of American College of Nutrition 2005, 24:257-265.
3. Arsenault J., Lehoux J., Lanthier L., Cabana J., Guillemette G., Lavigne P., et al. A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity. Pharmacogenetics and Genomics 2010, 20:377-388.
4. Ashar M.N., Chand R. Antihypertensive peptides purified from milks fermented with Lactobacillus delbrueckii ssp. bulgaricus. Milchwissenschaft 2004, 59:14-17.
5. Boelsma E., Kloek J. IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial. Nutrition Journal 2010, 9:52. http://www.nutritionj.com/content/9/1/52.
6. Bütikofer U., Meyer J., Sieber R., Walther B., Wechsler D. Occurrence of the angiotensin-converting enzyme-inhibiting yripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of swiss origin. Journal of Dairy Science 2008, 91:29-38.
7. Bütikofer U., Meyer J., Sieber R., Wechsler D. Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses. International Dairy Journal 2007, 17:968-975.
8. Chaves-López C., Tofalo R., Serio A., Paparella A., Sacchetti G., Suzzi G. Yeasts from Colombian kumis as source of peptides with angiotensin I converting enzyme (ACE) inhibitory activity in milk. International Journal of Food Microbiology 2012, 159:39-46.
9. Chen H.-M., Muramoto K., Yamauchi F. Structural analysis of antioxidative peptides from soybean β-conglycinin. Journal of Agricultural and Food Chemistry 1995, 43:574-578.
10. Chen H.-M., Muramoto K., Yamauchi F., Fujimoto K., Nokihara K. Antioxidative properties of histidine-containing peptides designed from peptide fragments found in the digests of a soybean protein. Journal of Agricultural and Food Chemistry 1998, 46:49-53.
11. Chen H.-M., Muramoto K., Yamauchi F., Nokihara K. Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean peptide. Journal of Agricultural and Food Chemistry 1996, 44:2619-2623.
12. Chen G., Tsai J., Sun Pan B. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. International Dairy Journal 2007, 17:641-647.
13. Choi J., Sabikhi L., Hassan A., Anand S. Bioactive peptides in dairy products. International Journal of Dairy Technology 2012, 65:1-12.
14. Christensen J.E., Dudley E.G., Pederson J., Steele J.L. Peptidases and amino acid catabolism in lactic acid bacteria. Antonie Van Leeuwenhoek 1999, 76:217-246.
15. Cicero A.F.G., Aubin F., Azais-Braesco V., Borghi C. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in european subjects? A meta-analysis of randomized controlled trials. American Journal of Hypertension 2013, 26:442-449.
16. Cicero A., Gerocarni B., Laghi L., Borghi C. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. Journal of Human Hypertension 2010, 25:425-436.
17. Cordle C.T. Soy protein allergy: incidence and relative severity. Journal of Nutrition 2004, 134:1213S-1219S.
18. de Leeuw P.W., van der Zander K., Kroon A.A., Rennenberg R.M., Koning M.M. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Pressure 2009, 18:44-50.
19. Deacon C.F., Nauck M.A., Toft-Nielsen M., Pridal L., Willms B., Holst J.J. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 1995, 44:1126-1131.
20. Didelot S., Bordenave-Juchereau S., Rosenfeld E., Fruitier-Arnaudin I., Piot J.-M., Sannier F. Preparation of angiotensin-I-converting enzyme inhibitory hydrolysates from supplemented caprine whey fermentation by various cheese microflora. International Dairy Journal 2006, 16:976-983.
21. Durrieu C., Degraeve P., Chappaz S., Martial-Gros A. Immunomodulating effects of water-soluble extracts of traditional French Alps cheeses on a human T-lymphocyte cell line. International Dairy Journal 2006, 16:1505-1514.
22. Scientific opinion on the substantiation of health claims related to isoleucine-proline-proline (IPP) and valine-proline-proline (VPP) and maintenance of normal blood pressure (ID) 661, 1831, 1832, 2891, (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2012, 10:2715-2736. EFSA (European Food Safety Authority).
23. Eigenmann P.A. The spectrum of cow's milk allergy. Pediatric Allergy and Immunology 2007, 18:265-271.
24. Engberink M.F., Schouten E.G., Kok F.J., van Mierlo L.A., Brouwer I.A., Geleijnse J.M. Lactotripeptides show no effect on human blood pressure results from a double-blind randomized controlled trial. Hypertension 2008, 51:399-405.
25. Farvin S.K.H., Baron C.P., Nielsen N.S., Jacobsen C. Antioxidant activity of yoghurt peptides: part 1-in vitro assays and evaluation in ω-3 enriched milk. Food Chemistry 2010, 123(4):1081-1089.
26. Farvin S.K.H., Baron C.P., Nielsen N.S., Otte J., Jacobsen C. Antioxidant activity of yoghurt peptides: part 2 - characterisation of peptide fractions. Food Chemistry 2010, 123:1090-1097.
27. Fitzgerald R.J., Murray B.A. Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 2006, 59:118-125.
28. Foltz M., Cerstiaens A., van Meensel A., Mols R., van der Pijl P.C., Duchateau G.S.M.J.E., et al. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 2008, 29:1312-1320.
29. Foltz M., Meynen E.M., Bianco V., van Platerink C., Koning T.M.M.G., Kloek J., et al. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide are absorbed intact into the circulation. Journal of Nutrition 2007, 137:953-958.
30. Foltz M., van der Pijl P.C., Duchateau G.S.M.J.E. Current in vitro testing of bioactive peptides is not valuable. Journal of Nutrition 2010, 140:117-118.
31. Foucaud C., Juillard V. Accumulation of casein-derived peptides during growth of proteinase-positive strains of Lactococcus lactis in milk: their contribution to subsequent bacterial growth is impaired by their internal transport. Journal of Dairy Research 2000, 67:233-240.
32. Fuglsang A., Rattray F.P., Nilsson D., Nyborg N.C.B. Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie Van Leeuwenhoek 2003, 83:27-34.
33. Gibbs B.F., Zougmanb A., Massea R., Mulligan C. Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food. Food Research International 2004, 37:123-131.
34. Gobbetti M., Ferranti P., Smacchi F., Goffredi F., Addeo F. Production of angiotensin-I-converting enzyme inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricusSS1 and Lactococccus lactis subsp.cremoris FT4. Applied and Environmental Microbiology 2000, 66:3898-3904.
35. Gomez-Ruiz J.A., Ramos M., Recio I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. International Dairy Journal 2002, 12:697-706.
36. Gómez-Ruiz J.A., Ramos M., Recio I. Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. International Dairy Journal 2004, 14:1075-1080.
37. Gomez-Ruiz J.A., Taborda G., Amigo L., Recio I., Ramos M. Identification of ACE-inhibitory peptidesin different Spanish Cheesesby tandem mass spectrometry. European Food Research and Technology 2006, 223:595-601.
38. Gonzalez-Gonzalez C.R., Tuohy K.M., Jauregi P. Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: effects of calcium, pH and peptides on the ACE-inhibitory activity. International Dairy Journal 2011, 21:615-622.
39. Haileselassie S., Lee B., Gibbs B. Purification and identification of potentially bioactive peptides from enzyme-modified cheese. Journal of Dairy Science 1999, 82:1612-1617.
40. Hamme V., Sannier F., Piot J., Didelot S., Bordenave-Juchereau S. Crude goat whey fermentation by Kluyveromyces marxianus and Lactobacillus rhamnosus: contribution to proteolysis and ACE inhibitory activity. Journal of Dairy Research 2009, 76:152.
41. Harris T., Cook E., Kannel W., Schatzkin A., Goldman L. Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 1985, 7:118-124.
42. Hassan S.M. Soybean, nutrition and health. Soybean - bio-active compounds 2003, InTech, Available from. http://www.intechopen.com/books/soybean-bio-active-compounds/soybean-nutrition-and-health, 10.5772/50839. El-Shemy (Ed.).
43. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. The American Journal of Clinical Nutrition 1996, 64:767-771.
44. Hernández-Ledesma B., Amigo L., Ramos M., Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural and Food Chemistry 2004, 52:1504-1510.
45. Hernández-Ledesma B., del Mar Contreras M., Recio I. Antihypertensive peptides: production, bioavailability and incorporation into foods. Advances in Colloid and Interface Science 2011, 165:23-35.
46. Hernández-Ledesma B., Miralles B., Amigo L., Ramos M., Recio I. Identification of antioxidant and ACE-inhibitory peptides in fermented milk. Journal of the Science of Food and Agriculture 2005, 85:1041-1048.
47. Hirata H., Nakamura Y., Yada H., et al. Clinical effects of new sour milk drink on mild or moderate hypertensive subjects. Journal of New Remedies and Clinics 2002, 51:61-69.
48. Hirota T., Ohki K., Kawagishi R., Kajimoto Y., Mizuno S., Nakamura Y., et al. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertension Research 2007, 30:489-496.
49. Huang Y., Lai Y., Chou C. Fermentation temperature affects the antioxidant activity of the enzyme-ripened sufu, an oriental traditional fermented product of soybean. Journal of Bioscience and Bioengineering 2011, 112:49-53.
50. Inoue K., Gotou T., Kitajima H., Mizuno S., Nakazawa T., Yamamoto N. Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein. Journal of Bioscience and Bioengineering 2009, 108:111-115.
51. Itakura H., Ikemoto S., Terada S., et al. The effect of sour milk on blood pressure in untreated hypertensive and normotensive subjects. Journal of Japan Society of Clinical Nutrition 2001, 23:26-31.
52. Iwai K., Nakaya N., Kawasaki Y., Matsue H. Inhibitory effect of natto, a kind of fermented soybeans, on LDL oxidation in vitro. Journal of Agricultural and Food Chemistry 2002, 50:3592-3596.
53. Jäkälä P., Hakala A., Turpeinen A.M., Korpela R., Vapaatalo H. Casein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro attenuate the development of hypertension and improve endothelial function in salt-loaded Goto-Kakizaki rats. Journal of Functional Foods 2009, 1:366-374.
54. Jäkälä P., Vapaatalo H. Antihypertensive peptides from milk proteins. Pharmaceuticals 2010, 3:251-272.
55. Jarmołowska B., Kostyra E., Krawczuk S., Kostyra H. β-Casomorphin-7 isolated from Brie cheese. Journal of the Science of Food and Agriculture 1999, 79:1788-1792.
56. Jauhiainen T., Collin M., Narva M., Cheng Z.J., Poussa T., Vapaatalo H., et al. Effect of long-term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats. Milchwissenschaft 2005, 60:358-362.
57. Jauhiainen T., Vapaatalo H., Poussa T., Kyrönpalo S., Rasmussen M., Korpela R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-ambulatory blood pressure measurement. American Journal of Hypertension 2005, 18:1600-1605.
58. Jauhiainen T., Wuolle K., Vapaatalo H., Kerojoki O., Nurmela K., Lowrie C., et al. Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. International Dairy Journal 2007, 17:1216-1223.
59. Kajimoto O., Aihara K., Hirata H., Takahashi R., Nakamura Y. Hypotensive effects of the tablets containing lactotripeptides (VPP, IPP). Journal of Nutritional Food 2001, 4:51-61.
60. Kajimoto O., Kurosaki T., Mizutani J., Nagisa I., Kaneko K., Aihara K., et al. Antihypertensive effects of liquid yoghurts containing "lactotripeptides (VPP, IPP)" in mild hypertensive subjects. Journal of Nutritional Food 2002, 5:55-66.
61. Kajimoto O., Nakamura Y., Yada H., Moriguchi S., Hirata H., Takahashi T. Hypotensive effects of sour milk in subjects with mild or moderate hypertension. Journal of the Japanese Society for Food Science and Technology 2001, 54:347-354.
62. Kies, A. K., & Pijl Van Der, P. C. (February 16, 2012). Peptide availability, United States Patent Application US 2012/0040895 A1.
63. Kilpi E.E.-L., Kahala M.M., Steele J.L., Pihlanto A.M., Joutsjoki V.V. Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. International Dairy Journal 2007, 17:976-984.
64. Kim S.-H., Oh S. Fermented milk and yogurt. Milk and dairy products in human nutrition 2013, 338-356. Wiley-Blackwell, Oxford. Y.W. Park, G.F.W. Haenlein (Eds.).
65. Kitts D.D., Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 2003, 9:1309-1323.
66. Ko W., Cheng M., Hsu K., Hwang J. Absorption-enhancing treatments for antihypertensive activity of oligopeptides from tuna cooking juice: in vivo evaluation in spontaneously hypertensive rats. Journal of Food Science 2006, 71:S13-S17.
67. Korhonen H. Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods 2009, 1:177-187.
68. Korhonen H., Pihlanto A. Food-derived bioactive peptides-opportunities for designing future foods. Current Pharmaceutical Design 2003, 9:1297-1308.
69. Korhonen H., Pihlanto A. Bioactive peptides: production and functionality. International Dairy Journal 2006, 16:945-960.
70. Kuba M., Tanaka K., Tawata S., Takeda Y., Yasuda M. Angiotensin I-converting enzyme inhibitory peptides isolated from Tofuyo fermented soybean food. Bioscience, Biotechnology, and Biochemistry 2003, 67:1278-1283.
71. Kudoh Y., Matsuda S., Igoshi K., Oki T. Antioxidative peptide from milk fermented with Lactobacillus delbrueckii subsp. bulgaricus IFO13953. Nippon Shokuhin Kagaku Kaishi 2001, 48:44-55.
72. Kumar Malik D., Baboota S., Ahuja A., Hasan S., Ali J. Recent advances in protein and peptide drug delivery systems. Current Drug Delivery 2007, 4:141-151.
73. Kunji E.R., Mierau I., Hagting A., Poolman B., Konings W.N. The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek 1996, 70:187-221.
74. Kuwabara Y., Nagai S., Yoshimitsu N., Nakagawa I., Watanabe Y., Tamai Y. Antihypertensive effect of the milk fermented by culturing with various lactic acid bacteria and a yeast. Journal of Fermentation and Bioengineering 1995, 80:294-295.
75. Laffineur E., Genetet N., Leonil J. Immunomodulatory activity of β-casein permeate medium fermented by lactic acid bacteria. Journal of Dairy Science 1996, 79:2112-2120.
76. LeBlanc J.G., Matar C., Valdéz J.C., LeBlanc J., Perdigon G. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. Journal of Dairy Science 2002, 85:2733-2742.
77. Libby P. Inflammation and cardiovascular disease mechanisms. American Journal of Clinical Nutrition 2006, 83:456S-460S.
78. Lignitto L., Cavatorta V., Balzan S., Gabai G., Galaverna G., Novelli E., et al. Angiotensin-converting enzyme inhibitory activity of water-soluble extracts of Asiago d'allevo cheese. International Dairy Journal 2010, 20:11-17.
79. Lin M.Y., Yen C.L. Antioxidative ability of lactic acid bacteria. Journal of Agricultural and Food Chemistry 1999, 47:1460-1466.
80. Liu J.R., Chen M.J., Lin C.W. Antimutagenic and antioxidant properties of milk-kefir and soymilk-kefir. Journal of Agricultural and Food Chemistry 2005, 53:2467-2474.
81. Li F., Yin L., Cheng Y., Saito M. Angiotensin I-converting enzyme inhibitory activities of extracts from commercial chinese style fermented soypaste. Japan Agricultural Research Quarterly 2010, 44:167-172.
82. Lo W.M.Y., Li-Chan E.C.Y. Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. Journal of Agricultural and Food Chemistry 2005, 53:3369-3376.
83. Luoma S., Peltoniemi K., Joutsjoki V., Rantanen T., Tamminen M., Heikkinen I., et al. Expression of six peptidases from Lactobacillus helveticus in Lactococcus lactis. Applied and Environmental Microbiology 2001, 67:1232-1238.
84. Mallikarjun Gouda K.G., Gowda L.R., Rao A.G., Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). Journal of Agricultural and Food Chemistry 2006, 54:4568-4573.
85. Martinez-Villaluenga C., Ines Torino M., Martin V., Arroyo R., Garcia-Mora P., Estrella Pedrola I., et al. Multifunctional properties of soy milk fermented by Enterococcus faecium strains isolated from raw soy milk. Journal of Agricultural and Food Chemistry 2012, 60:10235-10244.
86. Matar C., Valdez J.C., Medina M., Rachid M., Perdigon G. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. Journal of Dairy Research 2001, 68:601-609.
87. Meisel H., Goepfert A., Günter S. ACE-inhibitory activities in milk products. Milchwissenschaft 1997, 52:307-311.
88. Meyer J., Bütikofer U., Walther B., Wechsler D., Sieber R. Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties. Journal of Dairy Science 2009, 92:826-836.
89. Mierlo van L.A., Koning M.M., van der Zander K., Draijer R. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. American Journal of Clinical Nutrition 2009, 89:617-623.
90. Minervini F., Algaron F., Rizzello C.G., Fox P.F., Monnet V., Gobbetti M. Angiotensin -converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Applied and Environmental Microbiology 2003, 69:5297-5305.
91. Muehlenkamp M., Warthesen J. β-Casomorphins: analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris. Journal of Dairy Science 1996, 79:20-26.
92. Muguerza B., Ramos M., Sanchez E., Manso M.A., Miguel M., Aleixandre A., et al. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. International Dairy Journal 2006, 16:61-69.
93. Murray B.A., FitzGerald R.J. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Current Pharmaceutical Design 2007, 13:773-791.
94. Nagpal R., Behare P., Rana R., Kumar A., Kumar M., Arora S., et al. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food & Function 2011, 2:18-27.
95. Nakahara T., Sano A., Yamaguchi H., Sugimoto K., Chikata H., Kinoshita E., et al. Antihypertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances. Journal of Agricultural and Food Chemistry 2010, 58:821-827.
96. Nakahara T., Yamaguchi H., Uchida R. Effect of temperature on the stability of various peptidases during peptide-enriched soy sauce fermentation. Journal of Bioscience and Bioengineering 2012, 113:355-359.
97. Nakamura Y., Kajimoto O., Kaneko K., Aihara K., Mizutani J., Ikeda N., et al. Effects of the liquid yogurts containing "lactotripeptide (VPP, IPP)" on high-normal blood pressure. Journal of Nutritional Food 2004, 7:123-137.
98. Nakamura Y., Yamamoto N., Sakai K., Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. Journal of Dairy Science 1995, 78:1253-1257.
99. Nielsen M.S., Martinussen T., Flambard B., Sørensen K.I., Otte J. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: effect of bacterial strain, fermentation pH, and storage time. International Dairy Journal 2009, 19:155-165.
100. Okamoto A., Hanagata H., Matsumoto E., Kawamura Y., Koizumi Y., Yanagida F. Angiotensin I converting enzyme inhibitory activities of various fermented foods. Bioscience, Biotechnology, and Biochemistry 1995, 59:1147-1149.
101. Ong L., Henriksson A., Shah N.P. Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Le Lait 2007, 87:149-165.
102. Ong L., Shah N.P. Release and identification of angiotensin-converting enzyme inhibitory peptides as influenced by ripening temperatures and probiotic adjuncts in Cheddar cheeses. LWT-Food Science and Technology 2008, 41:1555-1566.
103. Otte J., Shalaby S.M., Zakora M., Pripp A.H., El-Shabrawy S.A. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 2007, 17:488-503.
104. Ou C.C., Lu T.M., Tsai J.J., Yen J.H., Chen H.W., Lin M.Y. Antioxidative effect of lactic acid bacteria: intact cells vs. intracellular extracts. Journal of Food Biochemistry 2009, 17:209-216.
105. Pan D., Guo Y. Optimization of sour milk fermentation for the production of ACE-inhibitory peptides and purification of a novel peptide from whey protein hydrolysate. International Dairy Journal 2010, 20:472-479.
106. Pauletti G.M., Gangwar S., Knipp G.T., Nerurkar M.M., Okumu F.W., Tamura K., et al. Structural requirements for intestinal absorption of peptide drugs. Journal of Controlled Release 1996, 41:3-17.
107. Pauletti G.M., Gangwar S., Siahaan T.J., Aubé J., Borchardt R. Improvement of oral peptide bioavailability: peptidomimetics and prodrug strategies. Advanced Drug Delivery Reviews 1997, 27:235-256.
108. Phelan M., Kerins D. The potential role of milk-derived peptides in cardiovascular disease. Food & Function 2011, 2:153-167.
109. Pihlanto A. Antioxidative peptides derived from milk proteins. International Dairy Journal 2006, 16:1306-1314.
110. Pihlanto-Leppala A., Rokka T., Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal 1998, 8:325-331.
111. Pihlanto A., Korhonen H. Bioactive peptides and proteins. Advances in Food and Nutrition Research 2003, 47:175-276.
112. Pihlanto A., Virtanen T., Korhonen H. Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. International Dairy Journal 2010, 20:3-10.
113. Pripp A.H. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food & Nutrition Research 2008, 52. 10.3402/fnr.v52i0.1641.
114. Pripp A.H., Sørensen R., Stepaniak L., Sørhaug T. Relationship between proteolysis and angiotensin-I-converting enzyme inhibition in different cheeses. LWT-Food Science and Technology 2006, 39:677-683.
115. Quiros A., Ramos M., Muguerza B., Delgado M.A., Miguel M., Aleixandre A., et al. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 2007, 17:33-41.
116. Rahman T., Hosen I., Towhidul Islam M.M., Shekbar H.U. Oxidative stress and human health. Advances in Bioscience and Biotechnology 2012, 3:997-1019.
117. Rho S.J., Lee J., Chung Y.I., Kim Y., Lee H.G. Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract. Process Biochemistry 2009, 44:490-493.
118. Ricci-Cabello I., Olalla Herrera M., Artacho R. Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutrition Reviews 2011, 70:241-255.
119. Rodríguez-Figueroa J.C., González-Córdova A.F., Torres-Llanez M.J., Garcia H.S., Vallejo-Cordoba B. Novel angiotensin I-converting enzyme inhibitory peptides produced in fermented milk by specific wild Lactococcus lactis strains. Journal of Dairy Science 2012, 95:5536-5543.
120. Rodríguez-Figueroa J.C., Reyes-Díaz R., González-Córdova A.F., Troncoso-Rojas R., Vargas-Arispuro I., Vallejo-Cordoba B. Angiotensin-converting enzyme inhibitory activity of milk fermented by wild and industrial Lactococcus lactis strains. Journal of Dairy Science 2010, 93:5032-5038.
121. Rojas-Ronquillo R., Cruz-Guerrero A., Flores-Nájera A., Rodríguez-Serrano G., Gómez-Ruiz L., Reyes-Grajeda J.P., et al. Antithrombotic and angiotensin-converting enzyme inhibitory properties of peptides released from bovine casein by Lactobacillus casei Shirota. International Dairy Journal 2012, 26:147-154.
122. Rokka T., Syväoja E.-L., Tuominen J., Korhonen H. Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT-milk. Milchwissenschaft 1997, 52:675-678.
123. Roudot-Algaron F., Bars D., Kerhoas L., Einhorn J., Gripon J. Phosphopeptides from Comté cheese: nature and origin. Journal of Food Science 1994, 59(3):544-547.
124. Rutherford-Markwick K.J. Food proteins as a source of bioactive peptides with diverse functions. British Journal of Nutrition 2012, 108:S149-S157.
125. Ryhänen E., Pihlanto-Leppala A., Pahkala E. A new type of ripened, low-fat cheese with bioactive properties. International Dairy Journal 2001, 11:441-447.
126. Sabikhi L., Mathur B.N. Qualitative and quantative analysis of β-casomorphins in Edam cheese. Milchwissenschaft 2001, 56:198-200.
127. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health. Circulation 2006, 113:1034-1044.
128. Sagardia I., Iloro I., Elortza F., Bald C. Quantitative structure-activity relationship based screening of bioactive peptides identified in ripened cheese. International Dairy Journal 2013, 33:184-190. http://dx.doi.org/10.1016/j.idairyj.2012.12.006.
129. Saito T. Antihypertensive peptides derived from bovine casein and whey proteins. Bioactive components of milk 2008, Vol.606:295-317. Springer. Z. Bösze (Ed.).
130. Saito T., Nakamura T., Kitazawa H., Kawai Y., Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in gouda cheese. Journal of Dairy Science 2000, 83:1434-1440.
131. Sano J., Ohki K., Higuchi T., Aihara K., Mizuno S., Kajimoto O., et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. Journal of Medicinal Food 2005, 8:423-430.
132. Satake M., Enjoh M., Nakamura Y., Takano T., Kawamura Y., Arai S., et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Bioscience, Biotechnology, and Biochemistry 2002, 66:378-384.
133. Savijoki K., Ingmer H., Varmanen P. Proteolytic systems of lactic acid bacteria. Applied Microbiology and Biotechnology 2006, 71:394-406.
134. Seppo L., Jauhiainen T., Poussa T., Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 2003, 77:326-330.
135. Seppo L., Kerojoki O., Suomalainen T., Korpela R. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension - a pilot study on humans. Milchwissenschaft 2002, 57:124-127.
136. Shin Z., Yu R., Park S., Chung D., Ahn C., Nam H., et al. His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. Journal of Agricultural and Food Chemistry 2001, 49:3004-3009.
137. Sienkiewicz-Szłapka E., Jarmołowska B., Krawczuk S., Kostyra E., Kostyra H., Iwan M. Contents of agonistic and antagonistic opioid peptides in different cheese varieties. International Dairy Journal 2009, 19:258-263.
138. Singh T.K., Fox P.F., Healy Á. Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese. Journal of Dairy Research 1997, 64:433-443.
139. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., Nurminen M. Effect of long-term intake of milk products on blood pressure in hypertensive rats. Journal of Dairy Research 2002, 69:103-111.
140. Sipola M., Finckenberg P., Santisteban J., Korpela R., Vapaatalo H., Nurminen M. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. Journal of Physiology and Pharmacology 2001, 52:745-754.
141. Smacchi E., Gobbetti M. Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme and Microbial Technology 1998, 22:687-694.
142. Stressler T., Eisele T., Fischer L. Simultaneous monitoring of twelve angiotensin I converting enzyme inhibitory peptides during enzymatic β-casein hydrolysis using Lactobacillus peptidases. International Dairy Journal 2013, 30:96-102.
143. Tompa G., Laine A., Pihlanto A., Korhonen H.J.T., Rogelj I., Marnila P. Chemiluminescence of non-differentiated THP-1 promonocytes: developing an assay for screening anti-inflammatory milk proteins and peptides. Luminescence 2011, 26:251-258.
144. Torres-Llanez M., González-Córdova A., Hernandez-Mendoza A., Garcia H., Vallejo-Cordoba B. Angiotensin-converting enzyme inhibitory activity in Mexican Fresco cheese. Journal of Dairy Science 2011, 94:3794-3800.
145. Tsai J., Chen T., Pan B.S., Gong S., Chung M. Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk. Food Chemistry 2008, 106:552-558.
146. Tsai J.S., Lin Y.S., Pan B.S., Chen T.J. Antihypertensive peptides and γ-aminobutyric acid from prozyme 6 facilitated lactic acid bacteria fermentation of soymilk. Process Biochemistry 2006, 41:1282-1288.
147. Tuomilehto J., Lindström J., Hyyrynen J., Korpela R., Karhunen M.-L., Mikkola L., et al. Effect of ingesting sour milk fermented by Lactobacillus helveticus bacteria on blood pressure in subjects with mild hypertension. Journal of Human Hypertension 2004, 18:795-802.
148. Turpeinen A.M., Järvenpää S., Kautiainen H., Korpela R., Vapaatalo H. Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis. Annals of Medicine 2013, 45:51-56.
149. Ueno K., Mizuno K., Yamamoto N. Purification and characterization of an endopeptidase that has an important role in the carboxyl terminal processing of antihypertensive peptides in Lactobacillus helveticus CM4. Letters in Applied Microbiology 2004, 39:313-318.
150. Urista M.C., Fernandez A.R., Rodriguez R.F., Cuenca A.A., Jurado T.A. Review: production and functionality of active peptides from milk. Food Science and Technology Intrenational 2011, 17:293-317.
151. Usinger L., Jensen L.T., Flambard B., Linneberg A., Ibsen H. The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension. Journal of Human Hypertension 2010, 24:678-683.
152. Usinger L., Reimer C., Ibsen H. Fermented milk for hypertension. Cochrane Database of Systematic Reviews 2012, 4. 10.1002/14651858.CD008118.pub2.
153. van der Pijl P.C., Kies A.K., Ten Have G.A., Duchateau G.S., Deutz N.E. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 2008, 29:2196-2202.
154. Van der Zander K., Jäkel M., Bianco V., Koning M. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. Journal of Human Hypertension 2008, 22:804-806.
155. Vasiljevic T., Shah N.P. Fermented milk: health benefits beyond probiotic effect. Handbook of food products manufacturing 2007, 99-115. John Wiley &Sons, Inc., Hoboken. Y.H. Hui (Ed.).
156. Vermeirssen V., Van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 2004, 92:357-366.
157. Virtanen T., Pihlanto A., Akkanen S., Korhonen H. Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. Journal of Applied Microbiology 2007, 102:106-115.
158. Wang W., Mejia D., Gonzalez E. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Comprehensive Reviews in Food Science and Food safety 2005, 4:63-78.
159. Wang D., Wang L., Zhu F., Zhu J., Chen X.D., Zou L., et al. In vitro and in vivo studies on the antioxidant activities of the aqueous extracts of Douchi (a traditional Chinese salt-fermented soybean food). Food Chemistry 2008, 107:1421-1428.
160. Werle M., Bernkop-Schnürch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 2006, 30:351-367.
161. Williams A.G., Noble J., Tammam J., Lloyd D., Banks J.M. Factors affecting the activity of enzymes involved in peptide and amino acid catabolism in non-starter lactic acid bacteria isolated from Cheddar cheese. International Dairy Journal 2002, 12:841-852.
162. Wu J., Muir A.D. Isoflavone content and its potential contribution to the antihypertensive activity in soybean angiotensin I converting enzyme inhibitory peptides. Journal of Agricultural and Food Chemistry 2008, 56:9899-9904.
163. Xu J., Qin L., Wang P., Li W., Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008, 24:933-940.
164. Yamamoto N., Maeno M., Takano T. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. Journal of Dairy Science 1999, 82:1388-1393.
165. Yang C.Y., Dantzig A.H., Pidgeon C. Intestinal peptide transport systems and oral drug availability. Pharmaceutical Research 1999, 16:1331-1343.
166. Yang H.J., Park S., Pak V., Chung K.R., Kwon D.Y. Fermented soybean products and their bioactive compounds. Soybean and health 2011, Intech, Available from. http://www.intechopen.com/books/soybean-and-health/fermented-soybean-products-and-their-bioactive-compounds, H. El-Shemy (Ed.).
167. Yasuda K., Aihara K., Komazaki K., Mochii M., Nakamura Y. Effect of large high intake of tablets containing lactotripeptides (VPP, IPP) on blood pressure, pulse rate and clinical parameters in healthy volunteers. Journal of Nutritional Food 2001, 4:63-72.
168. Zhang J., Tatsumi E., Ding C., Li L. Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product. Food Chemistry 2006, 98:551-557.
169. Zhu X., Watanabe K., Shiraishi K., Ueki T., Noda Y., Matsui T., et al. Identification of ACE-inhibitory peptides in salt-free soy sauce that are transportable across caco-2 cell monolayers. Peptides 2008, 29:338-344.